Skip to main content
Erschienen in: European Radiology 8/2011

01.08.2011 | Oncology

Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility

verfasst von: C. Messiou, D. J. Collins, V. A. Morgan, N. M. deSouza

Erschienen in: European Radiology | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To establish normal bone marrow values of apparent diffusion coefficient (ADC) over an age range, compare them with metastatic and myelomatous involvement, to establish reproducibility and to optimise b values.

Methods

The ADCs of bone marrow in 7 volunteers (mean age 29.7 years), 34 volunteers (mean age 63.3 years) and 43 patients with metastatic and myelomatous involvement (mean age 65.5 years) were measured. In 9 volunteers diffusion weighted MRI was repeated within 7 days. b values were derived to optimise contrast between normal and pathological marrow.

Results

The mean ADC of bone marrow in younger volunteers was significantly higher than that of older volunteers. The coefficient of reproducibility was 14.8%. The ADC mean of metastatic and myeloma bone disease was \( {1}0{54} + / - {456} \times {1}0 ^{-6} {\text{mm}}^{2}{\text{s}} ^{-1} \). An ADC threshold of 655 × 10−6 mm2s−1 separated normal and abnormal marrow with a sensitivity and specificity of 90% and 93% respectively. Contrast between normal and abnormal marrow was optimal at b = 1389 smm−2.

Conclusion

The reproducibility of ADC measurements in bone is equivalent to published data for soft tissue with a high sensitivity and specificity for separating abnormal from age matched normal bone marrow. A b value of around 1,400 smm−2 is optimal for imaging bone marrow.
Literatur
1.
Zurück zum Zitat Gauvain KM, McKinstry RC, Mukherjee P et al (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR 177:449–454PubMed Gauvain KM, McKinstry RC, Mukherjee P et al (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR 177:449–454PubMed
2.
Zurück zum Zitat Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60PubMedCrossRef Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60PubMedCrossRef
3.
Zurück zum Zitat Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 188:1622–1635PubMedCrossRef Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 188:1622–1635PubMedCrossRef
4.
Zurück zum Zitat Charles-Edwards EM, deSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135–143PubMedCrossRef Charles-Edwards EM, deSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135–143PubMedCrossRef
5.
Zurück zum Zitat Messiou C, deSouza NM (2010) Diffusion weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring. Cancer Biomark 6:23–32 Messiou C, deSouza NM (2010) Diffusion weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring. Cancer Biomark 6:23–32
6.
Zurück zum Zitat Nonomumra Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757–760CrossRef Nonomumra Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757–760CrossRef
7.
Zurück zum Zitat Gutzeit A, Doert A, Froehlich JM et al (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333–343PubMedCrossRef Gutzeit A, Doert A, Froehlich JM et al (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333–343PubMedCrossRef
8.
Zurück zum Zitat Goudarzi B, Kishimoto R, Komatsu S et al (2010) Detection of bone metastases using diffusion weighted magnetic resonance imaging:comparison with 11C-methionine PET and bone scintigraphy. Magn Reson Imaging 28:372–379PubMedCrossRef Goudarzi B, Kishimoto R, Komatsu S et al (2010) Detection of bone metastases using diffusion weighted magnetic resonance imaging:comparison with 11C-methionine PET and bone scintigraphy. Magn Reson Imaging 28:372–379PubMedCrossRef
9.
Zurück zum Zitat Luboldt W, Küfer R, Blumstein N et al (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249:1017–1025PubMedCrossRef Luboldt W, Küfer R, Blumstein N et al (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249:1017–1025PubMedCrossRef
10.
Zurück zum Zitat Lee KC, Bradley DA, Hussain M et al (2007) A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9:1003–1011PubMedCrossRef Lee KC, Bradley DA, Hussain M et al (2007) A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9:1003–1011PubMedCrossRef
11.
Zurück zum Zitat Lee KC, Sud S, Meyer CR et al (2007) An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res 67:3524–3528PubMedCrossRef Lee KC, Sud S, Meyer CR et al (2007) An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res 67:3524–3528PubMedCrossRef
12.
Zurück zum Zitat Reischauer C, Froehlich JM, Koh DM et al (2010) Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps – initial observations. Radiology 257:523–531PubMedCrossRef Reischauer C, Froehlich JM, Koh DM et al (2010) Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps – initial observations. Radiology 257:523–531PubMedCrossRef
13.
Zurück zum Zitat Reese TG, Heid O, Weisskoff RM, Wedeen VJ (2003) Reduction of eddy-current induced distortion in diffusion MRI using twice refocused spin echo. Magn Reson Med 49:177–182PubMedCrossRef Reese TG, Heid O, Weisskoff RM, Wedeen VJ (2003) Reduction of eddy-current induced distortion in diffusion MRI using twice refocused spin echo. Magn Reson Med 49:177–182PubMedCrossRef
14.
Zurück zum Zitat Kingsley P (2006) Introduction to diffusion tensor imaging mathematics: part III. Tensor calculation, noise, simulations and opimisation. Concepts Magn Reson 28A:155–179CrossRef Kingsley P (2006) Introduction to diffusion tensor imaging mathematics: part III. Tensor calculation, noise, simulations and opimisation. Concepts Magn Reson 28A:155–179CrossRef
15.
Zurück zum Zitat Koh DM, Blackledge M, Collins D et al (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19:2728–2738PubMedCrossRef Koh DM, Blackledge M, Collins D et al (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19:2728–2738PubMedCrossRef
16.
Zurück zum Zitat Hatipoglu GH, Slevi A, Ciliz D, Yuksel E (2007) Quantitative and diffusion MR imaging as a new method to assess osteoporosis. AJNR 28:1934–1937PubMedCrossRef Hatipoglu GH, Slevi A, Ciliz D, Yuksel E (2007) Quantitative and diffusion MR imaging as a new method to assess osteoporosis. AJNR 28:1934–1937PubMedCrossRef
17.
Zurück zum Zitat Yeung DK, Wong SY, Griffith JF, Lau EM (2004) Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 19:222PubMedCrossRef Yeung DK, Wong SY, Griffith JF, Lau EM (2004) Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 19:222PubMedCrossRef
18.
Zurück zum Zitat Griffith JF, Yeung DKW, Antonio GE et al (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241:831–838PubMedCrossRef Griffith JF, Yeung DKW, Antonio GE et al (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241:831–838PubMedCrossRef
19.
Zurück zum Zitat Tang GY, Lv ZW, Tang RB et al (2010) Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Rad 65:377–381CrossRef Tang GY, Lv ZW, Tang RB et al (2010) Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Rad 65:377–381CrossRef
20.
Zurück zum Zitat Wilkins BS (1992) Histology of normal haemopoiesis: bone marrow histology. I. J Clin Pathol 45:645–649PubMedCrossRef Wilkins BS (1992) Histology of normal haemopoiesis: bone marrow histology. I. J Clin Pathol 45:645–649PubMedCrossRef
21.
Zurück zum Zitat Griffith JF, Yeung DK, Antonio GE et al (2005) Vertebral bone mineral density, marrow perfusion and fat content in normal and osteoporotic males: analysis using dynamic contrast enhanced NR and MR spectroscopy. Radiology 236:945–951PubMedCrossRef Griffith JF, Yeung DK, Antonio GE et al (2005) Vertebral bone mineral density, marrow perfusion and fat content in normal and osteoporotic males: analysis using dynamic contrast enhanced NR and MR spectroscopy. Radiology 236:945–951PubMedCrossRef
22.
Zurück zum Zitat Baur A, Huber A, Ertl-Wagner B et al (2001) Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR 22:366–372PubMed Baur A, Huber A, Ertl-Wagner B et al (2001) Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR 22:366–372PubMed
23.
Zurück zum Zitat Herneth AM, Philipp MO, Naude J et al (2002) Vertebral metastases: assessment with apparent diffusion coefficient. Radiology 225:889–894PubMedCrossRef Herneth AM, Philipp MO, Naude J et al (2002) Vertebral metastases: assessment with apparent diffusion coefficient. Radiology 225:889–894PubMedCrossRef
Metadaten
Titel
Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility
verfasst von
C. Messiou
D. J. Collins
V. A. Morgan
N. M. deSouza
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 8/2011
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2116-4

Weitere Artikel der Ausgabe 8/2011

European Radiology 8/2011 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.